Production (Stage)
Rakovina Therapeutics Inc.
RKV.V
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 912.40K | 188.80K | 1.01M | 130.90K | 330.40K |
| Total Receivables | 56.50K | 104.80K | 29.30K | 13.80K | 15.20K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 281.00K | 591.40K | 403.90K | 22.90K | 133.40K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 323.20K | -- | -- | -- | -- |
| Total Current Assets | 1.57M | 885.00K | 1.45M | 167.50K | 479.00K |
|
|
|||||
| Total Current Assets | 1.57M | 885.00K | 1.45M | 167.50K | 479.00K |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 2.76M | 3.04M | 3.10M | 3.24M | 3.42M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 4.34M | 3.93M | 4.55M | 3.40M | 3.90M |
|
|
|||||
| Total Accounts Payable | 227.40K | 523.80K | 698.50K | 151.10K | 5.70K |
| Total Accrued Expenses | 135.70K | 96.10K | 66.10K | 80.80K | 111.40K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 986.50K | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 1.35M | 619.90K | 764.50K | 231.90K | 117.10K |
|
|
|||||
| Total Current Liabilities | 1.35M | 619.90K | 764.50K | 231.90K | 117.10K |
| Long-Term Debt | -- | 1.03M | 1.00M | 999.20K | 1.01M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 1.35M | 1.65M | 1.77M | 1.23M | 1.13M |
|
|
|||||
| Common Stock & APIC | 13.41M | 12.22M | 11.64M | 10.74M | 10.99M |
| Retained Earnings | -10.42M | -10.00M | -9.13M | -8.62M | -8.27M |
| Treasury Stock & Other | 2.00K | 57.60K | 276.10K | 57.50K | 58.90K |
| Total Common Equity | 2.99M | 2.28M | 2.78M | 2.17M | 2.77M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 2.99M | 2.28M | 2.78M | 2.17M | 2.77M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 2.99M | 2.28M | 2.78M | 2.17M | 2.77M |
|
|
|||||